As more contagious SARS-CoV-2 virus variants emerge, we remain ready to respond with tailored peptide tools such as our PepMix™ peptide pools for cellular immune response profiling.
We would like to announce the launch of overlapping peptide pools representing the Spike protein and corresponding RBD domain of the new B.1.1.7 SARS-CoV-2 variant that has been first reported in the UK.
PepMixes™ for the mutated Spike protein and RBD domain of the South African variant 501.V2 will be available soon.
Furthermore, we are glad to complete our portfolio of common cold coronavirus antigens by providing all relevant NCAP proteins:
Please find the complete SARS-COV-2 genome represented as overlapping PepMix™ Peptide Pools in our catalog which now includes an expanded number of high quality, purified PepMix™ versions!
Please contact us with any questions or comments.